These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37182235)

  • 1. [Survival analysis].
    Martínez Pérez JA; Pérez Martínez PS
    Semergen; 2023; 49(5):101986. PubMed ID: 37182235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding survival analysis: actuarial life tables and the Kaplan-Meier plot.
    Barakat A; Mittal A; Ricketts D; Rogers BA
    Br J Hosp Med (Lond); 2019 Nov; 80(11):642-646. PubMed ID: 31707885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.
    Beuscart JB; Pagniez D; Boulanger E; Lessore de Sainte Foy C; Salleron J; Frimat L; Duhamel A
    BMC Nephrol; 2012 May; 13():31. PubMed ID: 22646159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
    Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S
    BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview on standard statistical methods for assessing exposure-outcome link in survival analysis (Part II): the Kaplan-Meier analysis and the Cox regression method.
    Abd ElHafeez S; Torino C; D'Arrigo G; Bolignano D; Provenzano F; Mattace-Raso F; Zoccali C; Tripepi G
    Aging Clin Exp Res; 2012 Jun; 24(3):203-6. PubMed ID: 23114547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaplan-Meier Survival, Actuarial Survival, Censoring, and Competing Events-What Is What?
    Hage A; Hage F
    Ann Thorac Surg; 2022 Jul; 114(1):40-43. PubMed ID: 35367199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical guide to understanding Kaplan-Meier curves.
    Rich JT; Neely JG; Paniello RC; Voelker CC; Nussenbaum B; Wang EW
    Otolaryngol Head Neck Surg; 2010 Sep; 143(3):331-6. PubMed ID: 20723767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional Survival After IPAA for Ulcerative and Indeterminate Colitis: Does Long-term Pouch Survival Improve or Worsen With Time?
    Feinberg AE; Lavryk O; Aiello A; Hull TL; Steele SR; Stocchi L; Holubar SD
    Dis Colon Rectum; 2020 Jul; 63(7):927-933. PubMed ID: 32243352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris PD; Ghali WA; Marshall DA
    Clin Orthop Relat Res; 2015 Nov; 473(11):3431-42. PubMed ID: 25804881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.
    Buettner S; Margonis GA; Kim Y; Gani F; Ethun CG; Poultsides GA; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2016 Dec; 23(13):4401-4409. PubMed ID: 27495279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring survival time: a probability-based approach useful in healthcare decision-making.
    Prescrire Int; 2011; 20(118):193-4. PubMed ID: 21751760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Analysis: Where, Why, What and How?
    Indrayan A; Tripathi CB
    Indian Pediatr; 2022 Jan; 59(1):74-79. PubMed ID: 34047720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Additive Interaction Using Survival Percentiles.
    Bellavia A; Bottai M; Orsini N
    Epidemiology; 2016 May; 27(3):360-4. PubMed ID: 26829157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical research XXI. From the clinical judgment to survival analysis].
    Rivas-Ruiz R; Pérez-Rodríguez M; Palacios L; Talavera JO
    Rev Med Inst Mex Seguro Soc; 2014; 52(3):308-15. PubMed ID: 24878091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures of follow-up in time-to-event studies: Why provide them and what should they be?
    Betensky RA
    Clin Trials; 2015 Aug; 12(4):403-8. PubMed ID: 26025565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding survival analysis: Kaplan-Meier estimate.
    Goel MK; Khanna P; Kishore J
    Int J Ayurveda Res; 2010 Oct; 1(4):274-8. PubMed ID: 21455458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposals on Kaplan-Meier plots in medical research and a survey of stakeholder views: KMunicate.
    Morris TP; Jarvis CI; Cragg W; Phillips PPJ; Choodari-Oskooei B; Sydes MR
    BMJ Open; 2019 Sep; 9(9):e030215. PubMed ID: 31575572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene Blue halves the long-term recurrence rate in acute pilonidal sinus disease.
    Doll D; Novotny A; Rothe R; Kristiansen JE; Wietelmann K; Boulesteix AL; Düsel W; Petersen S
    Int J Colorectal Dis; 2008 Feb; 23(2):181-7. PubMed ID: 17960395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots.
    Royston P; Parmar MK; Altman DG
    J Natl Cancer Inst; 2008 Jan; 100(2):92-7. PubMed ID: 18182621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.